Literature DB >> 16763890

Methylmalonic and propionic acidurias: management without or with a few supplements of specific amino acid mixture.

G Touati1, V Valayannopoulos, K Mention, P de Lonlay, P Jouvet, E Depondt, M Assoun, J C Souberbielle, D Rabier, H Ogier de Baulny, J-M Saudubray.   

Abstract

In a series of 137 patients with methylmalonic acidaemia (MMA) and propionic acidaemia (PA) diagnosed since the early 1970s, we report in more detail 81 patients (51 MMA and 30 PA) diagnosed between 1988 and 2005. In this series, 14% of patients died at initial access revealing the disease before or despite treatment, 18% died later, and the remainder (68%) are still alive. All patients were treated with the same protocol of enteral feeds with a low-protein diet adjusted to individual tolerance, carnitine, antibiotics, and only occasional use of an amino acid (AA) mixture. There was intensive follow-up and monitoring using measurements of urinary urea. Thirty-nine patients with severe forms, followed for more than 3 years, are analysed in particular detail. Of the 17 PA patients, 6 had moderate disability (all neonatal-onset forms), whereas 11 were normal or slightly delayed in their mental development. Four presented with cardiomyopathy, of whom 2 died. Of the 22 MMA patients, 13 presented in the neonatal period, of whom 3 died later, 2 are in renal failure and only 5 are still alive and have a normal or slightly delayed mental development. In the 9 patients with late-onset forms, there were no deaths and all patients but one have normal mental development. Among the 39 patients, only 40% were given an AA supplement at 3 years, and 50% between 6 and 11 years. The actual intake of natural protein was 0.92, 0.78 and 0.77 g/kg per day at 3, 6 and 11 years, respectively, in patients without AA supplementation, whereas it was 0.75, 0.74 and 0.54 g/kg per day in the group who received small quantities of AA (0.4-0.6 g/kg per day). In both groups, feeding disorders were frequent: 55% at 3 years, 35% at 6 years and 12% at 11 years. Many patients were given a food supplement by tube overnight or were even exclusively tube fed: 60% at 3 years, 48% at 6 years and still 27% at 11 years. Growth velocity was near the normal values. Plasma valine and isoleucine were low to very low, as were leucine and phenylalanine but to a lesser extent. Albumin, vitamins, trace elements and markers of bone metabolism were within the normal values. IGF1, 24-hour urine calcium and body mass density were low. Body composition showed a normal to low lean mass and a normal to high fat mass.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763890     DOI: 10.1007/s10545-006-0351-7

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  21 in total

1.  Clinical outcome and long-term management of 17 patients with propionic acidaemia.

Authors:  S B van der Meer; F Poggi; M Spada; J P Bonnefont; H Ogier; P Hubert; E Depondt; D Rapoport; D Rabier; C Charpentier; P Parvy; J Bardet; P Kamoun; J M Saudubray
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

2.  Long-term follow-up of 77 patients with isolated methylmalonic acidaemia.

Authors:  E R Baumgarter; C Viardot
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

3.  The management and long term outcome of organic acidaemias.

Authors:  J V Leonard; P Daish; E R Naughten; K Bartlett
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

4.  Liver transplantation for inborn errors of liver metabolism.

Authors:  Efienne M Sokal
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

Review 5.  Hepatocyte transplantation for liver-based metabolic disorders.

Authors:  Anil Dhawan; Ragai R Mitry; Robin D Hughes
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

6.  Propionylcarnitine excretion is not affected by metronidazole administration to patients with disorders of propionate metabolism.

Authors:  S P Burns; R A Iles; J M Saudubray; R A Chalmers
Journal:  Eur J Pediatr       Date:  1996-01       Impact factor: 3.183

7.  Clinical outcome of long-term management of patients with vitamin B12-unresponsive methylmalonic acidemia.

Authors:  S B van der Meer; F Poggi; M Spada; J P Bonnefont; H Ogier; P Hubert; E Depondt; D Rapoport; D Rabier; C Charpentier
Journal:  J Pediatr       Date:  1994-12       Impact factor: 4.406

8.  Anabolic effect of human growth hormone: management of inherited disorders of catabolic pathways.

Authors:  D Marsden; B A Barshop; S Capistrano-Estrada; M Rice; C Prodanos; D Sartoris; J Wolff; K L Jones; S Spector; W L Nyhan
Journal:  Biochem Med Metab Biol       Date:  1994-08

9.  Studies on requirements for amino acids in infants with disorders of amino acid metabolism. I. Effect of alanine.

Authors:  D G Kelts; D Ney; C Bay; J M Saudubray; W L Nyhan
Journal:  Pediatr Res       Date:  1985-01       Impact factor: 3.756

10.  Liver transplantation in two cases of propionic acidaemia.

Authors:  J S Schlenzig; F Poggi-Travert; J Laurent; D Rabier; D Jan; U Wendel; A C Sewell; Y Revillon; P Kamoun; J M Saudubray
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

View more
  38 in total

1.  Variable dietary management of methylmalonic acidemia: metabolic and energetic correlations.

Authors:  Natalie S Hauser; Irini Manoli; Jennifer C Graf; Jennifer Sloan; Charles P Venditti
Journal:  Am J Clin Nutr       Date:  2010-11-03       Impact factor: 7.045

2.  Oxidative stress parameters in urine from patients with disorders of propionate metabolism: a beneficial effect of L:-carnitine supplementation.

Authors:  Graziela S Ribas; Giovana B Biancini; Caroline Mescka; Carlos Y Wayhs; Angela Sitta; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2011-07-22       Impact factor: 5.046

3.  Impact of inborn errors of metabolism on admission and mortality in a pediatric intensive care unit.

Authors:  Philippe Jouvet; Guy Touati; Fabrice Lesage; Laurent Dupic; Marisa Tucci; Jean Marie Saudubray; Philippe Hubert
Journal:  Eur J Pediatr       Date:  2006-08-29       Impact factor: 3.183

4.  Nutritional and Pharmacological Management during Chemotherapy in a Patient with Propionic Acidaemia and Rhabdomyosarcoma Botryoides.

Authors:  E Martín-Hernández; P Quijada-Fraile; L Oliveros-Leal; Mt García-Silva; C Pérez-Cerdá; M Baro-Fernández; V Pérez-Alonso; Jl Vivanco
Journal:  JIMD Rep       Date:  2012-03-21

5.  Clinical characteristics and gene mutation analysis of methylmalonic aciduria.

Authors:  Qin Yi; Juanjuan Lv; Fengyan Tian; Hong Wei; Qin Ning; Xiaoping Luo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14

6.  The Nutritional Intake of Patients with Organic Acidaemias on Enteral Tube Feeding: Can We Do Better?

Authors:  Anne Daly; S Evans; A Gerrard; S Santra; S Vijay; A MacDonald
Journal:  JIMD Rep       Date:  2015-10-29

7.  Clinical characteristics and mutation analysis of propionic acidemia in Thailand.

Authors:  Nithiwat Vatanavicharn; Somporn Liammongkolkul; Osamu Sakamoto; Mahattana Kamolsilp; Achara Sathienkijkanchai; Pornswan Wasant
Journal:  World J Pediatr       Date:  2014-01-25       Impact factor: 2.764

8.  Long-term needs of adult patients with organic acidaemias: outcome and prognostic factors.

Authors:  E Martín-Hernández; P J Lee; A Micciche; S Grunewald; R H Lachmann
Journal:  J Inherit Metab Dis       Date:  2009-07-23       Impact factor: 4.982

9.  Peritoneal dialysis for chronic renal failure in a patient with methylmalonic acidaemia.

Authors:  Bemigho Etuwewe; Caroline A Jones; Shipra Mathur; Katherine P Wright; Andrew A M Morris
Journal:  Pediatr Nephrol       Date:  2008-12-02       Impact factor: 3.714

10.  Long-term rescue of a lethal murine model of methylmalonic acidemia using adeno-associated viral gene therapy.

Authors:  Randy J Chandler; Charles P Venditti
Journal:  Mol Ther       Date:  2009-10-27       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.